BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07Submission of Matters to a Vote of Security Holders.
On May 25, 2017, BioLife Solutions, Inc. (the Company) completed
its 2017 annual meeting of stockholders (the Annual Meeting). The
number of shares of stock entitled to vote at the Annual Meeting
was 13,298,883 consisting of 13,016,533 shares of common stock
and 282,350 shares of restricted stock (collectively, the Voting
Stock). The number of shares of Voting Stock present or
represented by valid proxy at the Annual Meeting was 10,757,883
shares. All matters submitted to a vote of the Company’s
stockholders at the Annual Meeting were approved, and Raymond
Cohen, Thomas Girschweiler, Andrew Hinson, Michael Rice, and
Joseph Schick were elected as directors.
The following is a tabulation of the voting on the proposals
presented at the Annual Meeting:
(i) To elect five (5) directors, each of whom will be elected for
a term of one year, or until the election and qualification of
their successors.
| Nominee | Shares Voted For | Shares Withheld | Broker Non-Vote | ||
| Raymond Cohen | 7,495,863 | 138,640 | 3,188,580 | ||
| Thomas Girschweiler | 7,577,712 | 56,791 | 3,188,580 | ||
| Andrew Hinson | 7,495,878 | 138,625 | 3,188,580 | ||
| Michael Rice | 7,578,919 | 55,584 | 3,188,580 | ||
| Joseph Schick | 7,495,778 | 138,725 | 3,188,580 |
(ii) To approve an amendment and restatement to the Companys 2013
Performance Incentive Plan to increase the number of authorized
shares of common stock available for issuance under the Plan from
3,100,000 to 4,100,000.
| Shares Voted For | Shares Voted Against | Shares Abstaining | Broker Non-Vote | ||
| 7,410,440 | 194,169 | 29,894 | 3,188,580 |
(iii) To ratify the appointment by the Board of Directors of
Peterson Sullivan LLP as the Companys independent registered
public accounting firm for the fiscal year ending December 31,
2017.
| Shares Voted For | Shares Voted Against | Shares Abstaining | Broker Non-Vote | ||
| 10,628,123 | 66,484 | 63,276 | 65,200 |
About BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS)
BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service. BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Recent Trading Information
BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) closed its last trading session 00.00 at 2.15 with 19,555 shares trading hands.